E20 Adaptive Designs for Clinical Trials
Introduction & Context In June 2025, the International Council for Harmonisation (ICH) released a draft guideline titled “Adaptive Designs for Clinical Trials (E20)”, currently under public consultation. U.S. Food and Drug Administration This draft, intended to harmonize global regulatory and scientific expectations, addresses the use of adaptive designs in confirmatory clinical trials (i.e., trials intended […]